Food and beverage diagnostics via ELISA and biochip array screening
Randox Food Diagnostics manufactures screening assays and diagnostic platforms for mycotoxins, antimicrobials, hormones, and drug residues in food, beverages, and animal feed. The hiring mix—engineering, ops, and quality roles across mid and junior levels—reflects concurrent scaling of manufacturing capacity and compliance infrastructure. Active projects span site expansion across UK and Ireland, new automation systems, and clinical toxicology panels, while pain points flag IT transformation and information security as near-term investment areas.
Notable leadership hires: Project Sales Lead
Randox Food Diagnostics supplies screening solutions to food producers, beverage manufacturers, and government laboratories worldwide. The product portfolio includes 35 ELISA assays and 20 multiplex screening platforms, built around proprietary biochip array technology approved by the USDA. Operations span diagnostics development, manufacturing, and quality assurance across multiple UK and Ireland sites. The company serves global export markets and operates alongside NHS health check programs and clinical toxicology services.
ELISA assays and multiplex screening platforms for detecting mycotoxins, antimicrobials, growth hormones, and drug residues in food, beverages, and animal feed. Portfolio includes 35 ELISAs and 20 multiplex platforms.
Core stack includes SAP and Sage ERP systems for operations, SolidWorks for design, Adobe Creative Suite for graphics, and Office tools. No active tech adoptions or replacements currently flagged.
Other companies in the same industry, closest in size